Buy Mersana Therapeutics Stock | MRSN Stock Price & Latest News | Public
MRSN

Mersana Therapeutics

$0.00 (0.00%)Today

    About MRSN

    Mersana Therapeutics, Inc. engages in the development and manufacture of antibody drug conjugates to improve patient outcomes in oncology indications. Its product candidates are XMT-1522, which focuses on breast cancer and non-small cell lung cancer (NSCLC) and XMT-1536...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.12
    -0.24
    -0.35
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.32

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,63B
    Volume43,13k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$26.64
    1 Year Low$3.32
    Open$24.27
    High$26.29
    Low$24.27

    Buy any stock with any amount of money.

    Download the App
    Download the app